CRMD
NASDAQ · Pharmaceuticals
Cormedix Inc
$7.44
-0.07 (-0.93%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+605.6% upside
Low Target
$41.99
Average Target
$52.50
High Target
$66.46
Current Price
$7.44
Current
$7.44
$7.44
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Scenario Analysis
Bear Case
$41.99
464.4%
Low target
Base Case
$52.50
+605.6%
Avg target
Bull Case
$66.46
+793.3%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$14.96
-50.3% from high
52-Week Low
$6.13
+21.4% from low
Target vs 52W High
$52.50
+250.9% vs high
Next Earnings Report
Aug 13, 2026 · Before Market Open
3d
until earnings
EPS Est: $0.24
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +12.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +15.5% |
| MRK | Buy | 36 | 69% | $159.27 | +23.9% |
| PFE | Hold | 36 | 39% | $33.90 | +26.7% |
| BMY | Hold | 35 | 40% | $174.50 | +169.6% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -36.1% |
| ZTS | Hold | 24 | 54% | $209.87 | +188.8% |